Last reviewed · How we verify
Valchlor 0.016 % Topical Gel
At a glance
| Generic name | Valchlor 0.016 % Topical Gel |
|---|---|
| Also known as | topical nitrogen mustard, mechlorethamine hydrochloride, mechlorethamine gel |
| Sponsor | Rochester Skin Lymphoma Medical Group, PLLC |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- HyBryte (Synthetic Hypericin) Versus Valchlor (Mechlorethamine) in the Treatment of CTCL (PHASE2)
- SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)
- Triamcinolone Acetonide Injections in Primary Cutaneous Lymphoma Plaques With a Novel Needle-free Drug-delivery System. (NA)
- Deep Phenotyping of Cutaneous T Cell Lymphoma, Type Mycosis Fungoides (NA)
- Mechlorethamine Induced Contact Dermatitis Avoidance Study (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: